The Food and Drug Administration approved on Friday the second biologic arthritis drug for Centocor Ortho Biotech Inc., a division of Johnson & Johnson.
The Food and Drug Administration approved on Friday the second biologic arthritis drug for Centocor Ortho Biotech Inc., a division of Johnson & Johnson.